Ester Prodrugs Corneal Penetration Aqueous Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for glaucoma face challenges in penetrating the cornea effectively due to the hydrophobic nature of ester prodrugs, which hinders their ability to diffuse into the aqueous humor, and they often lack sufficient solubility in aqueous solutions, making it difficult to formulate effective ophthalmic compositions that can reduce intraocular pressure.
Innovation Solution
Development of ester prodrugs with specific structural formulas, such as those represented by Formula (I), which include substituted alkyl or heteroalkyl groups, allowing for enhanced penetration through the cornea and solubility in both non-polar and aqueous media, when combined with pharmaceutical excipients, to form ophthalmic compositions that can be administered to treat glaucoma and other ocular diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If ester prodrugs are used to enhance drug penetration through the cornea, then penetration capability is improved, but hydrophobicity increases making it difficult to diffuse into aqueous humor
Solution Approach 1:
The patent modifies the chemical parameters of the prodrug by introducing specific hydrophilic substituents (such as hydroxyl groups, carboxylic acid groups, or amine groups) at defined positions in the molecular structure. This changes the polarity and solubility characteristics of the molecule, allowing it to maintain adequate hydrophobicity for corneal penetration while acquiring sufficient hydrophilicity to diffuse into aqueous humor.
Solution Approach 2:
The prodrug structure combines both hydrophobic and hydrophilic moieties within a single molecular framework. The hydrophobic regions facilitate penetration through the lipid-rich corneal epithelium, while hydrophilic regions enable diffusion into the aqueous humor. This composite molecular architecture resolves the contradiction between requiring hydrophobicity for membrane penetration and hydrophilicity for aqueous solubility.
2Speed
If ester prodrugs are used to enhance corneal penetration, then penetration capability is improved, but solubility in aqueous solutions decreases making formulation difficult
Solution Approach 1:
The patent systematically modifies molecular parameters by introducing ionizable groups (carboxylic acids, amines, or hydroxyls) that can form hydrogen bonds with water and increase aqueous solubility. These structural modifications change the physicochemical parameters of the prodrug without compromising its ability to penetrate the cornea, thereby resolving the formulation challenge.
3Speed
If highly hydrophobic esters are used to penetrate the cornea, then penetration capability is improved, but ability to diffuse into aqueous humor deteriorates
Solution Approach 1:
The patent applies local quality modification by placing hydrophilic substituents at specific positions on the prodrug molecule - typically at terminal positions or on side chains - while maintaining the core hydrophobic structure necessary for corneal penetration. This localized introduction of polar groups allows the molecule to exhibit dual characteristics: hydrophobic core for membrane penetration and polar periphery for aqueous diffusion.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed ester prodrugs effectively penetrate the cornea and achieve therapeutic levels in the anterior chamber, reducing intraocular pressure and providing a treatment option for glaucoma and other ocular conditions like macular degeneration, while maintaining stability and solubility in aqueous solutions.
Implementation Method 1
The use of prodrug esters, which are cleaved enzymatically (e.g., in the cornea) to regenerate the active compound
Implementation Method 2
Penetration of the drug through the cornea requires a balance of hydrophobic and hydrophilic characteristics. In order to diffuse into the cornea the drug must be sufficiently soluble in non-polar media, and it must be sufficiently soluble in aqueous media in order to diffuse out of the cornea into the aqueous humor
Data Source
AI summary
Described herein are ester prodrugs of gamma-lactam compounds of Formula (I): or pharmaceutically acceptable salt thereof, and methods of use of such compounds for the treatment of ocular diseases including, among other things, glaucoma and macular degeneration.